{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:28:04Z","timestamp":1764332884308,"version":"3.46.0"},"reference-count":24,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010760","name":"Van Y\u00fcz\u00fcnc\u00fc Y\u0131l University","doi-asserted-by":"publisher","award":["TYD-2025-11467"],"award-info":[{"award-number":["TYD-2025-11467"]}],"id":[{"id":"10.13039\/501100010760","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Pituitary adenomas are common intracranial tumors lacking specific non-invasive biomarkers. This study aimed to determine whether key metabolites and enzymes of the kynurenine pathway\u2014including indoleamine 2,3-dioxygenase (IDO), kynurenine (KYN), kynurenic acid (KYNA), kynurenine aminotransferase (KAT), quinolinic acid, and picolinic acid\u2014can serve as diagnostic biomarkers distinguishing patients with pituitary adenomas from healthy controls. Materials and Methods: We conducted a single-center, cross-sectional, case\u2013control study with 50 patients with pituitary adenomas and 35 healthy controls. Serum levels of IDO, KYN, KYNA, KAT, quinolinic acid, and picolinic acid were measured via enzyme-linked immunosorbent assay (ELISA). Statistical analyses included group comparisons (t-test\/Mann\u2013Whitney U), multivariate logistic regression to identify independent predictors, receiver operating characteristic (ROC) curve analysis to evaluate diagnostic performance (area under the curve, AUC), and partial least squares discriminant analysis (PLS-DA) for multivariate metabolic profiling. Results: Serum kynurenine, kynurenic acid, 3-hydroxykynurenine, picolinic acid, IDO and kynureninase were significantly higher in the pituitary adenoma group than in healthy controls (p &lt; 0.001), while tryptophan, kynurenine aminotransferase, anthranilic acid and quinolinic acid showed no significant differences. ROC analysis demonstrated excellent diagnostic accuracy, with KAT (AUC = 0.923) and KYNA (AUC = 0.901) showing the highest discrimination. Multivariate logistic regression identified IDO, KYN, and KYNA as independent predictors of pituitary adenoma (p &lt; 0.05). PLS-DA of the combined metabolite data also demonstrated clear separation between patients and controls, confirming distinct metabolic profiles between the groups. Conclusions: Kynurenine pathway metabolites and enzymes show strong potential as non-invasive biomarkers for pituitary adenomas. In particular, elevated KAT and KYNA levels demonstrated high diagnostic performance. These findings suggest that a panel of kynurenine pathway metabolites could aid in the early, non-invasive detection of pituitary adenomas.<\/jats:p>","DOI":"10.3390\/medicina61122120","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:19:51Z","timestamp":1764328791000},"page":"2120","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum Kynurenine Pathway Metabolites as Candidate Diagnostic Biomarkers for Pituitary Adenoma: A Case\u2013Control Study"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0897-2819","authenticated-orcid":false,"given":"Nur D\u00fczen","family":"Oflas","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Van Yuzuncu Yil, 65090 Van, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4303-7837","authenticated-orcid":false,"given":"Halil \u0130brahim","family":"Akbay","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Medicine, University of Van Yuzuncu Yil, 65090 Van, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5318-9981","authenticated-orcid":false,"given":"Murat","family":"Alay","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Faculty of Medicine, University of Van Yuzuncu Yil, 65090 Van, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5439-9473","authenticated-orcid":false,"given":"Mehmet","family":"Erdem","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, University of Van Yuzuncu Yil, 65090 Van, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","article-title":"The Epidemiology of Pituitary Adenomas","volume":"49","author":"Daly","year":"2020","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"ref_2","unstructured":"Russ, S., Anastasopoulou, C., and Shafiq, I. (2023). Pituitary Adenoma, StatPearls Publishing."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11102-025-01562-9","article-title":"The clinicopathological PANOMEN-3 classification predicts pituitary adenoma prognosis: A real-world retrospective single center study of a surgically treated cohort","volume":"28","author":"Chiloiro","year":"2025","journal-title":"Pituitary"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e230021","DOI":"10.1530\/ERC-23-0021","article-title":"The World Health Organization classifications of pituitary neuroendocrine tumours: A clinico-pathological appraisal","volume":"30","author":"Villa","year":"2023","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e70703","DOI":"10.1002\/cam4.70703","article-title":"The Kynurenine Pathway and Indole Pathway in Tryptophan Metabolism Influence Tumor Progression","volume":"14","author":"Lu","year":"2025","journal-title":"Cancer Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1178646917691938","DOI":"10.1177\/1178646917691938","article-title":"Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"Int. J. Tryptophan Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17448069241275097","DOI":"10.1177\/17448069241275097","article-title":"Understanding the kynurenine pathway: A narrative review on its impact across chronic pain conditions","volume":"20","author":"Hazrati","year":"2024","journal-title":"Mol. Pain."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coi.2021.03.005","article-title":"Tryptophan metabolism in brain tumors-IDO and beyond","volume":"70","author":"Platten","year":"2021","journal-title":"Curr. Opin. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Song, X., Si, Q., Qi, R., Liu, W., Li, M., Guo, M., Wei, L., and Yao, Z. (2021). Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.800630"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Meireson, A., Devos, M., and Brochez, L. (2020). IDO Expression in Cancer: Different Compartment, Different Functionality?. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.531491"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Le\u00f3n-Letelier, R.A., Dou, R., Vykoukal, J., Sater, A.H.A., Ostrin, E., Hanash, S., and Fahrmann, J.F. (2023). The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1256769"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1158\/1078-0432.CCR-18-0041","article-title":"Tryptophan Metabolism Contributes to Radiation-Induced Immune Checkpoint Reactivation in Glioblastoma","volume":"24","author":"Kesarwani","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2217\/cns.12.6","article-title":"Shaping the glioma immune microenvironment through tryptophan metabolism","volume":"1","author":"Platten","year":"2012","journal-title":"CNS Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.15698\/cst2020.01.210","article-title":"Kynurenine: An oncometabolite in colon cancer","volume":"4","author":"Venkateswaran","year":"2020","journal-title":"Cell Stress."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.lungcan.2009.05.001","article-title":"Increased serum kynurenine\/tryptophan ratio correlates with disease progression in lung cancer","volume":"67","author":"Suzuki","year":"2010","journal-title":"Lung Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Icer, M.A., Ko\u00e7ak, T., Acar-Tek, N., Yesil, S., and Icer, Y. (2025). Serum neopterin and kynurenine as predictive and prognostic biomarkers in prostate cancer: The role of dietary inflammatory index and biomarker interactions. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-14300-y"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Walczak, K., and Krasowska, D. (2025). HCAR3 and Kynurenic Acid in Cancer: A Promising Axis of Immunometabolic Regulation or a Scientific Mirage?. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136269"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pharep.2013.06.007","article-title":"Kynurenic acid inhibits proliferation and migration of human glioblastoma T98G cells","volume":"66","author":"Walczak","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00726-012-1247-5","article-title":"Kynurenic acid in human renal cell carcinoma: Its antiproliferative and antimigrative action on Caki-2 cells","volume":"43","author":"Walczak","year":"2012","journal-title":"Amino Acids"},{"key":"ref_21","first-page":"221","article-title":"Tryptophan and its metabolites in patients with oral squamous cell carcinoma: Preliminary study","volume":"51","author":"Tankiewicz","year":"2006","journal-title":"Adv. Med. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/ijc.32555","article-title":"Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3)","volume":"146","author":"Huang","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_23","first-page":"123","article-title":"Antitumor activity of picolinic acid in CBA\/J mice","volume":"68","author":"Leuthauser","year":"1982","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_24","first-page":"607","article-title":"Antiproliferative activity of picolinic acid due to macrophage activation","volume":"13","author":"Ruffmann","year":"1987","journal-title":"Drugs Exp. Clin. Res."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/12\/2120\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:15:22Z","timestamp":1764332122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/12\/2120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":24,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["medicina61122120"],"URL":"https:\/\/doi.org\/10.3390\/medicina61122120","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]}}}